Skip to main content

O'Kane Kieran's Form 4 filing

Biodesix Inc (BDSX) · filed May 13, 2025

Accession no.
0000905148-25-001607
Filed
May 13, 2025, 6:35 PM ET
Trade date
May 9-13, 2025
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $169.89. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
O'Kane KieranCIK 0001828131Officer (Chief Commercial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 9, 2025Common StockMOption exerciseAcquired+1,490––139,529Direct
May 12, 2025Common StockSSaleDisposed−239$0.3594−$85.9139,290Direct
May 13, 2025Common StockSSaleDisposed−238$0.3529−$83.99139,052Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 9, 2025Common StockMOption exerciseDisposed−1,490$0.00$04,468Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)